De Hert MA - Search Results

1

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.

De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. De Hert MA, et al. Schizophr Res. 2006 Mar;83(1):87-93. doi: 10.1016/j.schres.2005.12.855. Epub 2006 Feb 14. Schizophr Res. 2006. PMID: 16481149 Free article.

2

[Drug-induced diabetes mellitus: the exemple of atypical antipsychotics].

Scheen AJ, De Hert M. Scheen AJ, et al. Rev Med Liege. 2005 May-Jun;60(5-6):455-60. Rev Med Liege. 2005. PMID: 16035311 Free article. French.

3

Oral glucose tolerance tests in treated patients with schizophrenia. Data to support an adaptation of the proposed guidelines for monitoring of patients on second generation antipsychotics?

De Hert M, Van Eyck D, Hanssens L, Peuskens H, Thys E, Wampers M, Scheen A, Peuskens J. De Hert M, et al. Eur Psychiatry. 2006 Jun;21(4):224-6. doi: 10.1016/j.eurpsy.2005.05.011. Epub 2005 Aug 31. Eur Psychiatry. 2006. PMID: 16139484 Free article. Clinical Trial.

4

Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring.

De Hert M, van Eyck D, De Nayer A. De Hert M, et al. Int Clin Psychopharmacol. 2006 Mar;21 Suppl 2:S11-5. doi: 10.1097/01.yic.0000201496.23259.85. Int Clin Psychopharmacol. 2006. PMID: 16601508 Review.

5

Usefulness of glycosylated haemoglobin (HbA1c) to screen for diabetes in patients with schizophrenia.

Hanssens L, De Hert M, Van Eyck D, Wampers M, Scheen A, Peuskens J. Hanssens L, et al. Schizophr Res. 2006 Jul;85(1-3):296-7. doi: 10.1016/j.schres.2006.03.038. Epub 2006 May 11. Schizophr Res. 2006. PMID: 16690257 Free article. No abstract available.

6

Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up study.

van Winkel R, Myin-Germeys I, Delespaul P, Peuskens J, De Hert M, van Os J. van Winkel R, et al. Schizophr Res. 2006 Dec;88(1-3):47-54. doi: 10.1016/j.schres.2006.06.033. Epub 2006 Aug 10. Schizophr Res. 2006. PMID: 16904292

7

A case series: evaluation of the metabolic safety of aripiprazole.

De Hert M, Hanssens L, van Winkel R, Wampers M, Van Eyck D, Scheen A, Peuskens J. De Hert M, et al. Schizophr Bull. 2007 May;33(3):823-30. doi: 10.1093/schbul/sbl037. Epub 2006 Aug 29. Schizophr Bull. 2007. PMID: 16940338 Free PMC article.

8

Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE.

De Hert M, Peuskens B, van Winkel R, Kalnicka D, Hanssens L, Van Eyck D, Wyckaert S, Peuskens J. De Hert M, et al. Schizophr Res. 2006 Dec;88(1-3):222-6. doi: 10.1016/j.schres.2006.07.025. Epub 2006 Sep 22. Schizophr Res. 2006. PMID: 16996250

9

Reversibility of antipsychotic treatment-related diabetes in patients with schizophrenia: a case series of switching to aripiprazole.

De Hert M, Hanssens L, van Winkel R, Wampers M, Van Eyck D, Scheen A, Peuskens J. De Hert M, et al. Diabetes Care. 2006 Oct;29(10):2329-30. doi: 10.2337/dc-06-1393. Diabetes Care. 2006. PMID: 17003321 Free article. No abstract available.

10

Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: evaluation of incidence and screening methods.

van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J. van Winkel R, et al. J Clin Psychiatry. 2006 Oct;67(10):1493-500. doi: 10.4088/jcp.v67n1002. J Clin Psychiatry. 2006. PMID: 17107239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters